Revvity Total Long-Term Assets 2010-2025 | RVTY

Revvity total long-term assets from 2010 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Revvity total long-term assets for the quarter ending March 31, 2025 were $10.043B, a 3.19% decline year-over-year.
  • Revvity total long-term assets for 2024 were $10.043B, a 4.93% decline from 2023.
  • Revvity total long-term assets for 2023 were $10.564B, a 2.56% decline from 2022.
  • Revvity total long-term assets for 2022 were $10.841B, a 13.68% decline from 2021.
Revvity Annual Total Long-Term Assets
(Millions of US $)
2024 $10,043
2023 $10,564
2022 $10,841
2021 $12,560
2020 $5,721
2019 $5,164
2018 $4,741
2017 $4,892
2016 $3,087
2015 $3,133
2014 $3,059
2013 $2,902
2012 $2,930
2011 $2,973
2010 $2,124
2009 $2,175
Revvity Quarterly Total Long-Term Assets
(Millions of US $)
2025-03-31 $10,043
2024-12-31 $10,043
2024-09-30 $10,321
2024-06-30 $10,266
2024-03-31 $10,373
2023-12-31 $10,564
2023-09-30 $10,508
2023-06-30 $10,695
2023-03-31 $10,843
2022-12-31 $10,841
2022-09-30 $10,707
2022-06-30 $12,082
2022-03-31 $12,394
2021-12-31 $12,560
2021-09-30 $12,649
2021-06-30 $6,479
2021-03-31 $6,088
2020-12-31 $5,721
2020-09-30 $5,190
2020-06-30 $5,105
2020-03-31 $5,043
2019-12-31 $5,164
2019-09-30 $4,941
2019-06-30 $5,061
2019-03-31 $4,839
2018-12-31 $4,741
2018-09-30 $4,697
2018-06-30 $4,755
2018-03-31 $4,892
2017-12-31 $4,892
2017-09-30 $3,193
2017-06-30 $3,171
2017-03-31 $3,224
2016-12-31 $3,087
2016-09-30 $3,151
2016-06-30 $3,115
2016-03-31 $3,161
2015-12-31 $3,133
2015-09-30 $2,958
2015-06-30 $3,012
2015-03-31 $3,006
2014-12-31 $3,059
2014-09-30 $2,812
2014-06-30 $2,856
2014-03-31 $2,873
2013-12-31 $2,902
2013-09-30 $2,903
2013-06-30 $2,905
2013-03-31 $2,911
2012-12-31 $2,930
2012-09-30 $2,949
2012-06-30 $2,903
2012-03-31 $2,956
2011-12-31 $2,973
2011-09-30 $2,472
2011-06-30 $2,520
2011-03-31 $2,218
2010-12-31 $2,124
2010-09-30 $2,270
2010-06-30 $2,222
2010-03-31 $2,136
2009-12-31 $2,175
2009-09-30 $2,208
2009-06-30 $2,126
2009-03-31 $2,078
Sector Industry Market Cap Revenue
Medical Medical Services $11.400B $2.755B
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $141.373B 26.51
Elevance Health (ELV) United States $87.880B 11.34
CVS Health (CVS) United States $87.261B 10.85
Cencora (COR) United States $58.118B 20.22
Natera (NTRA) United States $23.068B 0.00
DiDi Global (DIDIY) China $23.062B 24.50
Labcorp Holdings (LH) United States $21.972B 17.82
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.845B 0.00
Solventum (SOLV) United States $13.121B 13.89
CochLear (CHEOY) Australia $12.902B 0.00
ICON (ICLR) Ireland $11.746B 10.92
Viatris (VTRS) United States $10.481B 3.60
Avantor (AVTR) United States $9.172B 13.33
HealthEquity (HQY) United States $9.059B 39.68
Medpace Holdings (MEDP) United States $9.021B 23.96
Sonic Healthcare (SKHHY) Australia $8.561B 0.00
Charles River Laboratories (CRL) United States $7.452B 14.60
Caris Life Sciences,�Inc (CAI) $6.798B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.602B 27.10
BrightSpring Health Services (BTSG) United States $4.147B 38.05
Sotera Health (SHC) United States $3.156B 17.93
Surgery Partners (SGRY) United States $2.849B 37.05
Alignment Healthcare (ALHC) United States $2.770B 0.00
Concentras Parent (CON) United States $2.637B 15.24
GeneDx Holdings (WGS) United States $2.634B 101.44
Organon (OGN) United States $2.516B 2.67
PACS (PACS) United States $1.969B 0.00
Ardent Health (ARDT) United States $1.954B 8.33
Progyny (PGNY) United States $1.886B 41.51
Premier (PINC) United States $1.806B 13.71
GoodRx Holdings (GDRX) United States $1.779B 35.57
Teladoc Health (TDOC) United States $1.528B 0.00
Establishment Labs Holdings (ESTA) $1.235B 0.00
Pediatrix Medical (MD) United States $1.233B 9.38
CareDx (CDNA) United States $1.088B 16.99
Agilon Health (AGL) United States $0.952B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.919B 0.00
QDM (QDMI) Hong Kong, SAR China $0.840B 0.00
AMN Healthcare Services Inc (AMN) United States $0.791B 7.41
Nutex Health (NUTX) United States $0.692B 10.47
LifeMD (LFMD) United States $0.619B 0.00
Embecta (EMBC) United States $0.566B 3.82
InnovAge Holding (INNV) United States $0.498B 0.00
Enhabit (EHAB) United States $0.488B 40.17
SBC Medicals (SBC) United States $0.481B 0.00
Omada Health (OMDA) $0.471B 0.00
Sonida Senior Living (SNDA) United States $0.471B 0.00
Auna S.A (AUNA) Luxembourg $0.459B 10.33
So-Young (SY) China $0.314B 0.00
Performant Healthcare (PHLT) United States $0.313B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.262B 0.00
Beauty Health (SKIN) United States $0.241B 0.00
Oncology Institute (TOI) United States $0.183B 0.00
DocGo (DCGO) United States $0.160B 26.17
Pheton Holdings (PTHL) China $0.121B 0.00
Sera Prognostics (SERA) United States $0.104B 0.00
KindlyMD (NAKA) United States $0.083B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
NeueHealth (NEUE) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.055B 0.00
ModivCare (MODV) United States $0.045B 0.00
Biodesix (BDSX) United States $0.041B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.034B 0.00
Basel Medical Group (BMGL) Singapore $0.033B 0.00
OSR Holdings (OSRH) United States $0.027B 0.00
Intelligent Bio Solutions (INBS) United States $0.012B 0.00
Co-Diagnostics (CODX) United States $0.009B 0.00
BioNexus Gene Lab (BGLC) $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
SeaStar Medical Holding (ICU) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.002B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00